All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
Economy

Global Cardiovascular Clinical Trials Market Size To Exceed USD 9.76 Billion...

admin
People

InterDigital and Philips to Showcase Volumetric Streaming Technologies Empowering Immersive Sports...

admin
Pr Newswire

Essential Pharma reaches agreement with AGC Biologics for late phase clinical...

admin
Pr Newswire

ITC final initial determination Ruled in favor of Hugel (no violation...

admin
Pr Newswire

Global Registrational Phase III Study of Olverembatinib for the Treatment of...

admin
Economy

Classic Delight LLC Issues Public Health Alert Due to Possible Health...

admin
Pr Newswire

RSMC President’s Asia Tour: A Glimpse into the Future of Globalized...

admin
Economy

Northwest China’s Yangling setting benchmark for SCO agriculture technology cooperation for...

admin
Pr Newswire

Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule...

admin
Pr Newswire

The Westin Surabaya Introduces the Next Generation Heavenly® Bed

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...